477 related articles for article (PubMed ID: 33717162)
1. Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function.
Alatshan A; Benkő S
Front Immunol; 2021; 12():630569. PubMed ID: 33717162
[TBL] [Abstract][Full Text] [Related]
2. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.
Duez H; Pourcet B
Front Endocrinol (Lausanne); 2021; 12():630536. PubMed ID: 33716981
[TBL] [Abstract][Full Text] [Related]
4. Role of NLRP3 inflammasome in inflammatory bowel diseases.
Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
[TBL] [Abstract][Full Text] [Related]
5. The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo.
Sebti Y; Ferri L; Zecchin M; Beauchamp J; Mogilenko D; Staels B; Duez H; Pourcet B
Methods Mol Biol; 2019; 1951():189-207. PubMed ID: 30825154
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
7. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
Jiang H; Gong T; Zhou R
Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
[TBL] [Abstract][Full Text] [Related]
8. All-Trans Retinoic Acid Enhances both the Signaling for Priming and the Glycolysis for Activation of NLRP3 Inflammasome in Human Macrophage.
Alatshan A; Kovács GE; Aladdin A; Czimmerer Z; Tar K; Benkő S
Cells; 2020 Jul; 9(7):. PubMed ID: 32630207
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
10. The NLRP3 inflammasome: contributions to inflammation-related diseases.
Chen Y; Ye X; Escames G; Lei W; Zhang X; Li M; Jing T; Yao Y; Qiu Z; Wang Z; Acuña-Castroviejo D; Yang Y
Cell Mol Biol Lett; 2023 Jun; 28(1):51. PubMed ID: 37370025
[TBL] [Abstract][Full Text] [Related]
11. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
12. The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome.
Menon MP; Hua KF
Front Immunol; 2020; 11():569524. PubMed ID: 33101288
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome in endothelial dysfunction.
Bai B; Yang Y; Wang Q; Li M; Tian C; Liu Y; Aung LHH; Li PF; Yu T; Chu XM
Cell Death Dis; 2020 Sep; 11(9):776. PubMed ID: 32948742
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome-A Key Player in Antiviral Responses.
Zhao C; Zhao W
Front Immunol; 2020; 11():211. PubMed ID: 32133002
[TBL] [Abstract][Full Text] [Related]
15. An update on the regulatory mechanisms of NLRP3 inflammasome activation.
Paik S; Kim JK; Silwal P; Sasakawa C; Jo EK
Cell Mol Immunol; 2021 May; 18(5):1141-1160. PubMed ID: 33850310
[TBL] [Abstract][Full Text] [Related]
16. Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications.
Irandoost E; Najibi S; Talebbeigi S; Nassiri S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):621-631. PubMed ID: 36542122
[TBL] [Abstract][Full Text] [Related]
17. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
Xu Q; Zhao B; Ye Y; Li Y; Zhang Y; Xiong X; Gu L
J Neuroinflammation; 2021 May; 18(1):123. PubMed ID: 34059091
[TBL] [Abstract][Full Text] [Related]
18. Cellular Models and Assays to Study NLRP3 Inflammasome Biology.
Zito G; Buscetta M; Cimino M; Dino P; Bucchieri F; Cipollina C
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560261
[TBL] [Abstract][Full Text] [Related]
19. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.
Meyers AK; Zhu X
Cells; 2020 Jul; 9(8):. PubMed ID: 32751530
[TBL] [Abstract][Full Text] [Related]
20. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.
Jiang D; Chen S; Sun R; Zhang X; Wang D
Cancer Lett; 2018 Apr; 419():8-19. PubMed ID: 29339210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
